| Percentage (%) people with advanced adenoma | Percentage (%) people with cancerous neoplasia | ||||||
---|---|---|---|---|---|---|---|---|
Male | Target | Female | Target | Male | Target | Female | Target | |
55–59 | 6.25 | 6.6 | 3.85 | 3.50 | 0.73 | 0.60 | 0.27 | 0.30 |
60–64 | 7.63 | 8.2 | 4.98 | 4.50 | 0.82 | 1.00 | 0.56 | 0.50 |
65–69 | 10.41 | 9.2 | 5.38 | 5.30 | 0.85 | 1.30 | 1.03 | 0.70 |
70–74 | 11.31 | 9.9 | 5.76 | 6.40 | 2.20 | 1.90 | 0.92 | 1.10 |
75–79 | 13.17 | 10.4 | 6.71 | 6.80 | 2.62 | 2.50 | 1.44 | 1.60 |